Compare Logitech International SA (LOGI) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs ResMed Inc. — how do they compare? Logitech International SA trades at $101.7 (market cap $14.65B), while ResMed Inc. trades at $196 (market cap $28.81B). The key difference: ResMed Inc. is the larger of the two by market cap, and Logitech International SA pays the higher dividend (1.67%). Which is the better fit depends on your goals.
| LOGI | RMD | |
|---|---|---|
Market Cap | $14.65B | $28.81B |
Sector | Technology | Health |
52-Week High | $126.69 | $293.73 |
52-Week Low | $85.84 | $182.82 |
Enterprise Value | $13.00B | $27.99B |
Dividend Yield | 1.67% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
